Buscar

01/06/2025 AMBISPECTIVE, MULTICENTER REGISTRY OF TREATMENT WITH ANIFROLUMAB IN REAL LIFE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS FROM SPANISH RHEUMATOLOGY DEPARTMENTS (ANIFRO-REU): EFFICACY AND SAFETY AT 3-AND 6-MONTH FOLLOW-UP VISITS
Salman-Monte, TC, Carrion-Barberá, I, Triginer, L, Riveros-Frutos, A, Font, J, Garcia-Villanueva, MJ, Garrote-Corral, S, Galindo, M, Polo, CD, González, IA, Bernabéu, P, Casasempere, PV, Morales, CM, Alvarez, ED, Cortés-Hernández, J, Moreno, SS, Giráldez, CR, Gil, JJF, Hernández, A, Magallares, BP, Garcia, MMP, Cid, CMF, Hernández, S, Ros, I, García-Aparicio, A, Sala-Icardo, L, Gómez-Puerta, JA, Frade-Sosa, B, Garcia-Cirera, S, Bufort, MG, Martínez-Barrio, J, de Salazar, JRG, del Amo, ND, Fito-Manteca, C, Torrente-Segarra, V, Heredia, S, Brandy-Garcia, A, Lucea, ER, Zarrabeitia, LR, Urruticoechea-Arana, A, Pego-Reigosa, JM, Rúa-Figueroa, IJ. AMBISPECTIVE, MULTICENTER REGISTRY OF TREATMENT WITH ANIFROLUMAB IN REAL LIFE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS FROM SPANISH RHEUMATOLOGY DEPARTMENTS (ANIFRO-REU): EFFICACY AND SAFETY AT 3-AND 6-MONTH FOLLOW-UP VISITS. ANNALS OF THE RHEUMATIC DISEASES. 2025; 84DOI:10.1136/annrheumdis-2025-eular.B1338. PMID:. IF:20.600(Q1/1D).
01/06/2025 A comparative analysis of risk stratification tools in SSc-associated pulmonary arterial hypertension: a EUSTAR analysis
Bjorkekjaer, HJ, Bruni, C, Broch, K, Brunborg, C, Carreira, PE, Airò, P, Simeón-Aznar, CP, Truchetet, ME, Giollo, A, Balbir-Gurman, A, Martin, M, Denton, CP, Gabrielli, A, Del Galdo, F, Vonk, MC, Fretheim, H, Bitter, H, Midtvedt,O, Andreassen, A, Hoie, S, Tanaka, Y, Riemekasten, G, Mueller-Ladner, U, Matucci-Cerinic, M, Castellví, I, Siegert, E, Hachulla, E, Molberg,O, Distler, O, Hoffmann-Vold, AM, EUSTAR Collaborators. A comparative analysis of risk stratification tools in SSc-associated pulmonary arterial hypertension: a EUSTAR analysis. RHEUMATOLOGY. 2025; 64(6)DOI:10.1093/rheumatology/keaf053. PMID:39878955. IF:4.400(Q1/1D).
22/04/2025 Platelet-Derived Soluble CD40L and Its Impact on Immune Modulation and Anti-IL6R Antibody Treatment Outcome in Rheumatoid Arthritis
Zamora, C, Diaz-Torne, C, Ortiz, MA, Moya, P, Park, HS, Pitarch, C, Cantó, E, Osuna-Gomez, R, Mulet, M, Garcia-Arguinzonis, M, Collado, D, Corominas, H, Vidal, S. Platelet-Derived Soluble CD40L and Its Impact on Immune Modulation and Anti-IL6R Antibody Treatment Outcome in Rheumatoid Arthritis. Cells. 2025; 14(9)DOI:10.3390/cells14090625. PMID:40358149. IF:5.200(Q2/3D).
28/03/2025 Interindividual variability and its impact on the effectiveness of Janus kinase inhibitors in rheumatoid arthritis treatment
Martinez-Molina, C, Vidal, S, Diaz-Torne, C, Park, HS, Corominas, H. Interindividual variability and its impact on the effectiveness of Janus kinase inhibitors in rheumatoid arthritis treatment. Frontiers in Medicine. 2025; 12DOI:10.3389/fmed.2025.1512501. PMID:40224626. IF:3.000(Q1/2D).
01/03/2025 Clinical and ultrasound optimization in rheumatoid arthritis for patients in sustained remission, can it work as a new optimization tool?
Añez, G, Torrente-Segarra, V, Bonet, M, Vilella, MC, Orpinell, L, Fernández, AP, Busquets-Pérez, N, Pascual-Pastor, M, Corominas, H, Diaz-Torne, C, Moya, P, De Agustin, JJ. Clinical and ultrasound optimization in rheumatoid arthritis for patients in sustained remission, can it work as a new optimization tool?. Journal Of Ultrasound. 2025; 28(1)DOI:10.1007/s40477-024-00963-z. PMID:39424691. IF:(Q/D).
01/01/2025 EULAR recommendations for the treatment of systemic sclerosis: 2023 update
Del Galdo, F, Lescoat, A, Conaghan, PG, Bertoldo, E, Colic, J, Santiago, T, Suliman, YA, Matucci-Cerinic, M, Gabrielli, A, Distler, O, Hoffmann-Vold, AM, Castellví, I, Balbir-Gurman, A, Vonk, M, Ananyeva, L, Rednic, S, Tarasova, A, Ostojic, P, Boyadzhieva, V, El Aoufy, K, Farrington, S, Galetti, I, Denton, CP, Kowal-Bielecka, O, Mueller-Ladner, U, Allanore, Y. EULAR recommendations for the treatment of systemic sclerosis: 2023 update. ANNALS OF THE RHEUMATIC DISEASES. 2025; 84(1)DOI:10.1136/ard-2024-226430. PMID:39874231. IF:20.600(Q1/1D).
01/01/2025 Mepolizumab efficacy and safety in patients with eosinophilic granulomatosis with polyangiitis in real practice: Data from a Spanish retrospective multicentric register from Rheumatology departments
Juárez, FR, de Vicuña, RG, Vicente, E, Almaraz, ER, Rivas, NL, González, MF, Marqués, AO, Nack, A, García, JN, Alvarado, PM, Itzazelaia, EU, Lorenzo, NA, de la Fuente, JLM, Ramos, C, Aransay, VP, Alonso, RB, Villanueva, FB, Vidal, MPM, Martín, JMG, Rúa-Figueroa, I. Mepolizumab efficacy and safety in patients with eosinophilic granulomatosis with polyangiitis in real practice: Data from a Spanish retrospective multicentric register from Rheumatology departments. Reumatologia Clinica. 2025; 21(1)DOI:10.1016/j.reuma.2024.10.007. PMID:. IF:(Q/D).
01/11/2024 Effectiveness Of Tocilizumab In Aortitis And Aneurysms Associated With Giant Cell Arteritis
Martín-Gutiérrez, A, Loricera, J, Narváez, J, Aldasoro, V, Maiz, O, Vela, P, Romero-Yuste, S, de Miguel, E, Galíndez-Agirregoikoa, E, Fernández-López, JC, Ferraz-Amaro, I, Sánchez-Martín, J, Moya, P, Campos, C, Lopez-Gutierrez, F, Castaneda, S, Blanco, R. Effectiveness Of Tocilizumab In Aortitis And Aneurysms Associated With Giant Cell Arteritis. European Journal of Internal Medicine. 2024; 129DOI:10.1016/j.ejim.2024.06.013. PMID:38908981. IF:6.100(Q1/1D).
01/11/2024 Comparative Analysis of Classification Criteria in IgG4-Related Disease and Evaluating Diagnostic Accuracy from a Retrospective Cohort in Clinical Practice
Lopez-Gomez, M, Moya-Alvarado, P, Park, HS, Martín, MC, Calleja, S, Codes-Mendez, H, Magallares, B, Castellví, I, Barros-Membrilla, AJ, Laiz, A, Diaz-Torné, C, Sainz, L, Bernárdez, J, Martínez-Martinez, L, Corominas, H. Comparative Analysis of Classification Criteria in IgG4-Related Disease and Evaluating Diagnostic Accuracy from a Retrospective Cohort in Clinical Practice. Diagnostics. 2024; 14(22)DOI:10.3390/diagnostics14222583. PMID:39594249. IF:3.300(Q1/2D).
18/10/2024 Familial aortic aneurysm: a case presentation
Codes-Méndez, H, Moya-Alvarado, P, Corominas, H. Familial aortic aneurysm: a case presentation. MEDICINA CLINICA. 2024; 163(7)DOI:. PMID:38926034. IF:2.100(Q2/3D).
01/10/2024 Clinical and Serological Profiles in Cryoglobulinemia: Analysis of Isotypes and Etiologies
Codes-Méndez, H, Jeria, S, Park, HS, Moya, P, Magallares-López, B, Moltó, E, Alvaro, Y, Mariscal, A, Moga, E, Tandaipan, JL, Díaz-Torne, C, Laiz, A, Sainz, L, Castellví, I, Corominas, H. Clinical and Serological Profiles in Cryoglobulinemia: Analysis of Isotypes and Etiologies. Journal of Clinical Medicine. 2024; 13(20)DOI:10.3390/jcm13206069. PMID:39458019. IF:2.900(Q1/2D).
01/10/2024 18F-FDG-PET/CT Scan for Detection of Large Vessel Involvement in Giant Cell Arteritis: Arteser Spanish Registry
Estrada, P, Domínguez-Alvaro, M, Melero-González, RB, de Miguel, E, Silva-Díaz, M, Valero, JA, González, I, Sánchez-Martín, J, Narváez, J, Galíndez, E, Mendizábal, J, Iñiguez-Ubiaga, CL, Rodríguez-Rodríguez, L, Loricera, J, Muñoz, A, Moya-Alvarado, P, Moran-alvarez, P, Navarro-angeles, VA, Galisteo, C, Castañeda, S, Blanco, R. 18F-FDG-PET/CT Scan for Detection of Large Vessel Involvement in Giant Cell Arteritis: Arteser Spanish Registry. Journal of Clinical Medicine. 2024; 13(20)DOI:10.3390/jcm13206215. PMID:39458165. IF:2.900(Q1/2D).
01/10/2024 Update of the Consensus Statement of the Spanish Society of Rheumatology on the use of biological and synthetic targeted therapies in rheumatoid arthritis.
Álvaro-Gracia Álvaro JM, Díaz Del Campo Fontecha P, Andréu Sánchez JL, Balsa Criado A, Cáliz Cáliz R, Castrejón Fernández I, Corominas H, Gómez Puerta JA, Manrique Arija S, Mena Vázquez N, Ortiz García A, Plasencia Rodríguez C, Silva Fernández L, Tornero Molina J. Update of the Consensus Statement of the Spanish Society of Rheumatology on the use of biological and synthetic targeted therapies in rheumatoid arthritis.. Reumatologia Clinica. 2024; 20(8)DOI:10.1016/j.reumae.2024.09.002. PMID:39341701. IF:(Q/D).
01/09/2024 Ultrasound in Rheumatology, It is a Must
Corominas, H, Badlissi, F. Ultrasound in Rheumatology, It is a Must. European Journal Of Rheumatology. 2024; 11DOI:10.5152/eurjrheum.2024.250324. PMID:39308354. IF:(Q/D).
01/09/2024 Ultrasound for the Diagnosis of Giant Cell Arteritis
Alarcón, PVE, Alvarado, PM, Alierta, ELS. Ultrasound for the Diagnosis of Giant Cell Arteritis. European Journal Of Rheumatology. 2024; 11DOI:10.5152/eurjrheum.2024.20104. PMID:39311386. IF:(Q/D).
01/09/2024 SSc-PAH patients are at risk of disease progression in contemporary clinical practice
Bjorkekjær, HJ, Bruni, C, Brunborg, C, Carreira, P, Airò, P, Simeón-Aznar, CP, Truchetet, ME, Giollo, A, Balbir-Gurman, A, Martin, M, Denton, CP, Gabrielli, A, Fretheim, H, Bitter, H, Midtvedt, O, Broch, K, Andreassen, A, Hoie, S, Tanaka, Y, Riemekasten, G, Müller-Ladner, U, Matucci-Cerinic, M, Castellví, I, Siegert, E, Hachulla, E, Molberg, O, Distler, O, Hoffmann-Vold, AM. SSc-PAH patients are at risk of disease progression in contemporary clinical practice. EUROPEAN RESPIRATORY JOURNAL. 2024; 64DOI:10.1183/13993003.congress-2024.PA2493. PMID:. IF:21.000(Q1/1D).
01/09/2024 ACR/EULAR 2022 Classification Criteria Compared to the ACR 1990 Classification Criteria in the ARTESER Registry of Giant Cell Arteritis
De Miguel, E, Hern ndez-Rodr guez, I, Silva-Diaz, M, Belzunegui, JM, Moya, P, Tortosa-Caba as, M, Navarro, VA, Calvet, J, Casafont-Sol , I, Rom n-Ivorra, JA, Labrada-Arrabal, S, Rocha, MV, I iguez, CL, Hern ndez-Hern ndez, V, Campos-Fern ndez, C, Villar, MA, Juan-Mas, A, Prado-Galbarro, FJ, Calvo, I, S nchez-Mart n, J, Narvaez-Garc a, J, Blanco-Alonso, R. ACR/EULAR 2022 Classification Criteria Compared to the ACR 1990 Classification Criteria in the ARTESER Registry of Giant Cell Arteritis. Arthritis & Rheumatology. 2024; 76DOI:. PMID:. IF:10.900(Q1/1D).
01/09/2024 Clinical Patterns and Long-term Outcomes of Arthritis Triggered by Immune Checkpoint Inhibitors. A Multicenter Study
Narvaez-Garc a, J, Llobell, A, Ponce, A, Gomez-Centeno, A, Mill n, AM, Corominas, H, Nolla, JM, Gomez-Puerta, JA. Clinical Patterns and Long-term Outcomes of Arthritis Triggered by Immune Checkpoint Inhibitors. A Multicenter Study. Arthritis & Rheumatology. 2024; 76DOI:. PMID:. IF:10.900(Q1/1D).
01/09/2024 Ambispective, Multicenter Registry of Treatment with Anifrolumab in Real Life in Patients with Systemic Lupus Erythematosus from Spanish Rheumatology Departments (ANIFRO-Reu): Efficacy, Safety and Patient's Characteristics
Carri n-Barber , I, Monte, TCS, Triginer, L, Garc a-Villanueva, M, Corral, SG, Frutos, AR, Font, J, Galindo-Izquierdo, M, Polo, CDF, Gil, JJF, Moriano, C, Alvarez, ED, Bernab u, P, Vela-Casasempere, P, Cortes-Hern ndez, J, Moreno, SS, Narvaez-Garc a, J, Hern ndez-Mart n, A, Magallares, BP, Garc a, MP, Marras, C, Ramos, C, Gomez-Puerta, JA, Frade-Sosa, B, Fern ndez-Ortiz, A, Garcia-Aparicio, A, Altab s-Gonz lez, I, Hern ndez-Baldiz n, S, Ros-Vilamajo, I, Cirera, SG, Bufort, MG, Sala, L, Mart nez-Barrio, J, de Salazar, JRG, Heredia, S, Torrente-Segarra, V, Brandy-Garcia, AM, Del Amo, NDV, Fito-Manteca, C, Calvo-Alen, J, Pego-Reigosa, JM, R a-Figueroa, I. Ambispective, Multicenter Registry of Treatment with Anifrolumab in Real Life in Patients with Systemic Lupus Erythematosus from Spanish Rheumatology Departments (ANIFRO-Reu): Efficacy, Safety and Patient's Characteristics. Arthritis & Rheumatology. 2024; 76DOI:. PMID:. IF:10.900(Q1/1D).
01/09/2024 Sustained Drug-free Remission in Giant Cell Arteritis: Results Results of the Spanish ARTESER Registry
Narvaez-Garc a, J, Dominguez-Alvaro, M, Gal ndez-Agirregoikoa, E, Mendizabal, J, Alcazar, IA, Loricera, J, Garrido-Pu al, N, Casta eda, S, Moya, P, Larena, C, Estrada-Alarc n, P, Galisteo, C, Frutos, AR, Sanjuan, FO, Monte, TCS, Rocha, MV, Ubiaga, CLI, Garcia-Gonzalez, M, Blanco-Alonso, R. Sustained Drug-free Remission in Giant Cell Arteritis: Results Results of the Spanish ARTESER Registry. Arthritis & Rheumatology. 2024; 76DOI:. PMID:. IF:10.900(Q1/1D).